PharmaEssentia USA @pharmaessentia.bsky.social · 04/08/2026We’re growing at PharmaEssentia and looking for passionate talent to join our team across a range of functions. Come help shape the future of biopharmaceutical innovation with us. Explore opportunities: us.pharmaessentia.com/careers/ 000
PharmaEssentia USA @pharmaessentia.bsky.social · 27/07/2026Last week, our Director of Patient Advocacy, Jennifer Porter, attended the annual Chief Patient Officer Summit in Boston, where biopharma leaders discussed elevating patient voices, advancing advocacy, and embedding patient-centric strategies across industry work. 000
PharmaEssentia USA @pharmaessentia.bsky.social · 17/07/2026Understanding ET means understanding the potential risks and complications that may come with the disease over time. Learn more about blood clot risks, disease progression, and other ET-related symptoms at piecetogetheret.com 000
PharmaEssentia USA @pharmaessentia.bsky.social · 14/07/2026A new episode of MPN Pod is here! Our hosts sit down with Dr. Tony Hunter, an MPN specialist at Emory University, to break down what Essential Thrombocythemia (ET) is, how it’s diagnosed, and the driver mutations behind the disease. Listen now: podcasts.apple.com/us/podcast/e... 000
PharmaEssentia USA @pharmaessentia.bsky.social · 09/07/2026Explore the downloadable Piece Together ET Guide — created to support education and awareness for those navigating Essential Thrombocythemia (ET). Learn more at: piecetogetheret.com 000
PharmaEssentia USA @pharmaessentia.bsky.social · 06/07/2026This morning we announced that Health Canada has issued a Notice of Compliance (NOC) authorizing BESREMi® (ropeginterferon alfa-2b) for the treatment of adults with polycythemia vera (PV). Read the full press release: us.pharmaessentia.com/pharmaessent... 000
PharmaEssentia USA @pharmaessentia.bsky.social · 02/07/2026Our people drive everything we do at PharmaEssentia. Proud to foster a culture built on collaboration, purpose, and innovation as we continue advancing care for patients worldwide. 000
PharmaEssentia USA @pharmaessentia.bsky.social · 26/06/2026Today we’re excited to announce the FDA approval and U.S. launch of the BESREMi Pen™ (ropeginterferon alfa-2b-njft) device, a new administration option for patients. us.pharmaessentia.com/pharmaessent... 000
PharmaEssentia USA @pharmaessentia.bsky.social · 22/06/2026Our Patient Advocacy and Patient Marketing teams attended this year’s World Orphan Drug Congress in Boston—bringing together the rare disease community to share insights, spotlight innovation, and support efforts advancing therapies and access for patients. #WODC #WODC2026 000
PharmaEssentia USA @pharmaessentia.bsky.social · 17/06/2026We believe that better science starts with the right people. We're growing our team and looking for passionate, mission-driven individuals who want to make a meaningful difference for patients living with rare blood cancers. us.pharmaessentia.com/careers/ 000
PharmaEssentia USA @pharmaessentia.bsky.social · 16/06/2026Thank you to everyone who connected with us at #EHA2026. It was a valuable opportunity to engage with the global hematology community and share new research in MPNs, including Dr. Harry Gill’s presentation of two-year Phase 3 SURPASS-ET findings in essential thrombocythemia. 000
PharmaEssentia USA @pharmaessentia.bsky.social · 11/06/2026PharmaEssentia has agreed to acquire FORUS Therapeutics, our Canadian commercial partner, for Canadian Dollar 50 million, completing our North American commercial footprint. us.pharmaessentia.com/pharmaessent... 000
PharmaEssentia USA @pharmaessentia.bsky.social · 09/06/2026The PharmaEssentia team is heading to #EHA2026 in Stockholm! We’re excited to share new data from our Phase 3 SURPASS-ET study in essential thrombocythemia. Read more: www.businesswire.com/news/home/20... 000
PharmaEssentia USA @pharmaessentia.bsky.social · 08/06/2026We just launched Piece Together ET — a new resource for people living with essential thrombocythemia (ET). Find answers, tools, and community support. piecetogetheret.com #EssentialThrombocythemia #MPN 000
PharmaEssentia USA @pharmaessentia.bsky.social · 03/06/2026Great to be part of #ASCO26 alongside the oncology community. We return home energized by the science, conversations, and shared commitment to improving patient outcomes. 000
PharmaEssentia USA @pharmaessentia.bsky.social · 29/05/2026A new episode of MPN Pod is live. 🎙️ In this conversation we catch back up with Gary Linehan to see what’s been working well for him as he continues to navigate his PV journey and where he’s planning to hike next. Listen now: podcasts.apple.com/us/podcast/m... 000
PharmaEssentia USA @pharmaessentia.bsky.social · 27/05/2026We're thrilled to welcome Eric Vogel as our new U.S. Head of Commercialization. With 20+ years of oncology & hematology commercial leadership, Eric will help drive global commercial expansion. www.businesswire.com/news/home/20... 000
PharmaEssentia USA @pharmaessentia.bsky.social · 22/05/2026We look forward to joining the global oncology community at #ASCO26, where PharmaEssentia will present new research highlighting our ongoing work in hematology. Attending ASCO? Stop by to learn more about our latest research. Read more: www.businesswire.com/news/home/20... 000
PharmaEssentia USA @pharmaessentia.bsky.social · 21/05/2026The PharmaEssentia team was proud to support the 2026 #ONSCongress and engage with oncology nurses through valuable educational conversations focused on MPN care and patient support. Thank you for an inspiring few days of connection and collaboration. 000
PharmaEssentia USA @pharmaessentia.bsky.social · 19/05/2026PharmaEssentia is proud to partner with the MPN Research Foundation and sponsor the annual MPN Roundtable™, May 12–13 in Chicago. The event brings together patients, caregivers, physician-scientists, and industry leaders to identify unmet needs and advance patient-focused science. 000
PharmaEssentia USA @pharmaessentia.bsky.social · 18/05/2026Employee Spotlight💡 Jennifer Porter, our Director of Patient Advocacy, shares what excites her most about the year ahead—the growing momentum across PharmaEssentia to support the MPN community and strengthen the resources and support available to patients. 000
PharmaEssentia USA @pharmaessentia.bsky.social · 14/05/2026MPN Asia 2026 – Seoul It was a pleasure connecting with clinicians and experts across the region on May 9 for thoughtful discussions on #MPN research and patient care. Exchanging perspectives across the global community helps strengthen how we move forward together. 000
PharmaEssentia USA @pharmaessentia.bsky.social · 12/05/2026Thank you to everyone who joined us in Birmingham and Detroit. The conversations were thoughtful and collaborative, focused on supporting people living with Polycythemia Vera. Next stop: 📍 May 16 – Minneapolis, MN Learn more and register: www.pvinfocus.com 000
PharmaEssentia USA @pharmaessentia.bsky.social · 08/05/2026We’re attending #ISPORAnnual — ISPOR Annual Meeting in Philadelphia (May 17–20). Looking forward to connecting with peers and discussing the evolving role of health economics and outcomes research in #oncology and beyond. If attending, stop by our poster session. 010
PharmaEssentia USA @pharmaessentia.bsky.social · 06/05/2026How is Essential Thrombocythemia (ET) diagnosed? Because ET can feel silent at first, diagnosis often begins with routine blood work. Swipe to learn about the common tests used. Source: mpnresearchfoundation.org/essential-th... 000
PharmaEssentia USA @pharmaessentia.bsky.social · 04/05/2026📍 May 16 – Minneapolis, MN We’re looking forward to continuing meaningful conversations with the #PolycythemiaVera community—sharing insights, learning from one another, and supporting people living with PV. Register: www.pvinfocus.com 000
PharmaEssentia USA @pharmaessentia.bsky.social · 30/04/2026With strong global momentum and important milestones ahead in 2026, we are expanding our team across functions and looking for curious, collaborative people ready to make an impact. Explore roles: us.pharmaessentia.com/careers/ 000
PharmaEssentia USA @pharmaessentia.bsky.social · 27/04/2026Taiwan’s U.S. Representative Alexander Tah-ray Yui and Puerto Rico officials visited PharmaEssentia’s Puerto Rico facility on April 20—a key milestone as we advance our dual Taiwan–U.S. manufacturing strategy and strengthen global supply chain resilience. www.businesswire.com/news/home/20... 011
PharmaEssentia USA @pharmaessentia.bsky.social · 27/04/2026Thank you, New York. Pleased to have hosted the April 18 PV in Focus event with thoughtful discussion and strong engagement from the community. Next stops: 📍 May 2, Detroit 📍 May 16, Minneapolis Learn more and register: www.pvinfocus.com 000
PharmaEssentia USA @pharmaessentia.bsky.social · 22/04/2026Today is Earth Day 🌎 At PharmaEssentia, building better science also means thinking about long-term impact. Our ESG efforts focus on responsible operations, sustainable growth, and supporting the communities where we work. Learn more: www.pharmaessentia-esg.com/en 000
PharmaEssentia USA @pharmaessentia.bsky.social · 14/04/2026Stepping into a new chapter of leadership. As PharmaEssentia’s Head of Global Strategy, Harvey Chin is focused on thoughtful growth and how we continue building with clarity and purpose across our global teams. Watch a short clip where he shares his perspective. 000
PharmaEssentia USA @pharmaessentia.bsky.social · 09/04/2026We’re growing, and PharmaEssentia USA is hiring. 2026 is an exciting year for our U.S. team. As we continue to expand our presence and capabilities, we’re looking for curious and collaborative people who are ready to help build what’s next. Explore open roles: us.pharmaessentia.com/careers/ 000
PharmaEssentia USA @pharmaessentia.bsky.social · 06/04/2026Introducing MPN Pod🎙️ In our first episode, Dr. Tyler Parsons, a postdoctoral researcher who studies MPNs and is also a PV patient, shares his decade-long journey to diagnosis and how he found his “new center.” Listen here: podcasts.apple.com/us/podcast/a... 000
PharmaEssentia USA @pharmaessentia.bsky.social · 03/04/2026PV is in focus this spring. Join the #PolycythemiaVera community at upcoming PV in Focus events: 📍 Apr 18 – New York 📍 Apr 25 – Birmingham 📍 May 2 – Detroit, MI Learn more and register: www.pvinfocus.com 000
PharmaEssentia USA @pharmaessentia.bsky.social · 02/04/2026PharmaEssentia has signed an investment agreement for a new manufacturing facility in Puerto Rico, strengthening global manufacturing network and supply resilience. The Toa Baja site is targeted to begin operations in 2027, pending regulatory approvals. www.businesswire.com/news/home/20... 000
PharmaEssentia USA @pharmaessentia.bsky.social · 27/03/2026As PharmaEssentia enters a defining period of growth, Sam Lin, Head of Global Operations, is focused on disciplined execution. From aligning commercial strategy to strengthening global supply, his priorities center on scaling effectively and delivering for patients worldwide. 000
PharmaEssentia USA @pharmaessentia.bsky.social · 25/03/2026At PharmaEssentia, taking time to come together as a team is an important part of who we are. After a strong first quarter, we recently gathered to celebrate achievements, reflect on progress, and align on what’s ahead — all rooted in our shared commitment to patients. 000
PharmaEssentia USA @pharmaessentia.bsky.social · 23/03/2026Registration is still open for our NYC PV in Focus event on 4/18! This free event includes community-building activities, and keynotes on PV treatment options, patient perspectives, self-advocacy, and mental health. Breakfast and lunch will be provided at no cost. More info: www.pvinfocus.com 000
PharmaEssentia USA @pharmaessentia.bsky.social · 19/03/2026Essential thrombocythemia (ET) is a rare blood cancer characterized by the overproduction of platelets, which can increase the risk of blood clots and other complications. Learn more about the potential signs and symptoms of ET. Source: bloodcancerunited.org/blood-cancer... 001
PharmaEssentia USA @pharmaessentia.bsky.social · 11/03/2026Thanks to all who joined us in Fort Lauderdale for the first PV in Focus event of 2026! We’re energized by the meaningful conversations around polycythemia vera (PV) and patient care. Our next event will be in NYC on 4/18. See you there! More info: www.pvinfocus.com 000
PharmaEssentia USA @pharmaessentia.bsky.social · 03/03/2026It’s been a strong start to the year at PharmaEssentia, and we’re growing. Grounded in scientific rigor and a collaborative culture, we’re focused on improving outcomes for patients with myeloproliferative neoplasms and other serious conditions. Join us: us.pharmaessentia.com/careers/ 010
PharmaEssentia USA @pharmaessentia.bsky.social · 02/03/2026Today, we announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved the inclusion of a high-dose dosing regimen for BESREMi® (ropeginterferon alfa-2b) as an alternative dosing schedule in Japan. us.pharmaessentia.com/pharmaessent... 000
PharmaEssentia USA @pharmaessentia.bsky.social · 26/02/2026Rare diseases affect 300 million people worldwide. On #RareDiseaseDay, we recognize individuals and families living with MPNs, a group of rare blood cancers, and our continued commitment to advancing science for patients with unmet needs. #ShowYourStripes 010
PharmaEssentia USA @pharmaessentia.bsky.social · 24/02/2026To close out Season 2 of our podcast, we reflect on the themes that shaped this season—from lived experiences and shared challenges to insights on #PolycythemiaVera care, connection, and advocacy. Listen now: podcasts.apple.com/us/podcast/a... 000
PharmaEssentia USA @pharmaessentia.bsky.social · 19/02/2026Have you heard of essential thrombocythemia (ET)? ET is a rare blood cancer that can be easy to overlook, especially early on when symptoms may be mild or absent. Yet without awareness and ongoing care, ET can carry serious risks over time. Source: pubmed.ncbi.nlm.nih.gov/36780473/ 000
PharmaEssentia USA @pharmaessentia.bsky.social · 18/02/2026Our recent 2026 PharmaEssentia USA National Meeting in Orlando brought together teams from across the U.S. and around the globe for several days of connection, collaboration, and alignment on what’s ahead as we work toward shared goals in the year to come. 010
PharmaEssentia USA @pharmaessentia.bsky.social · 13/02/2026Lunar New Year is a time of reflection, renewal, and connection, celebrated across Asia for thousands of years. As we welcome the Year of the Fire Horse, symbolizing energy and resilience, we wish everyone health, prosperity, and new beginnings. 000
PharmaEssentia USA @pharmaessentia.bsky.social · 11/02/2026Behind every breakthrough at PharmaEssentia is a team driven by curiosity, collaboration, and a commitment to making a difference. We foster a culture where diverse perspectives are valued and people are supported in doing their best work. Join our team: us.pharmaessentia.com/careers/ 000
PharmaEssentia USA @pharmaessentia.bsky.social · 09/02/2026We’re thrilled that announce that we’re investing $46 million to establish a new, wholly owned manufacturing subsidiary in Puerto Rico, expanding our global footprint and beginning U.S.-based manufacturing. Read more: us.pharmaessentia.com/pharmaessent... 000
PharmaEssentia USA @pharmaessentia.bsky.social · 09/02/2026We’re excited to kick off the first PV in Focus event of 2026 in Fort Lauderdale on 2/28! PV in Focus brings people together for a day focused on education, shared experiences, and meaningful conversation around #PolycythemiaVera (PV). Learn more: www.pvinfocus.com 000
